Hogan Lovells Events | 12 - 14 January 2026
Hogan Lovells 3rd Annual Fireside Chat Series during J.P. Morgan 2026
We are pleased to invite you to the Hogan Lovells Life Sciences and Health Care fireside chat series at the Marriott Marquis San Francisco during the 44th Annual J.P. Morgan Healthcare Conference.
Check out our full program below and register for the sessions that most interest you.
Program Agenda
Monday, January 12 | 11:00 a.m. PT
Financing Your Product Development
Developing and launching a new life sciences product is a high-stakes endeavor — especially for emerging companies navigating the complexities of innovation protection, clinical data generation, regulation and commercialization. At this J.P. Morgan Healthcare conference fireside chat, attendees will hear about the essential criteria that venture capital firms look to see before they invest. Hogan Lovells lawyers will offer advice on structuring a successful Series A financing, managing the diligence process, considering novel regulatory paradigms, and executing a cost-effective intellectual property strategy here and abroad. Whether you're looking for funding or trying to make a deal, this session will equip you with the tools to launch with confidence and clarity in today’s dynamic life sciences landscape.
Monday, January 12 | 1:00 p.m. PT
FDA Priorities in 2026
As the life sciences industry navigates a rapidly shifting regulatory and geopolitical landscape, our fireside chat will explore what’s next for FDA and how companies can stay ahead.
We’ll unpack the agency’s shifting priorities and staffing changes, examine how the Trump administration’s policies continue to reshape the regulatory paradigm, and discuss critical developments such as upcoming user fee agreements, the Most Favored Nation (MFN) drug pricing model, and onshoring strategies. Join us for a candid conversation on what these changes mean for innovation, compliance, market access, and how to position your organization for success.
Monday, January 12 | 2:00 p.m. PT
Regulatory Readiness: Going Global – US, China, and Europe in Focus
As life sciences companies expand internationally, regulatory readiness must evolve into a strategic capability that supports global business planning and innovation. This fireside chat will explore how companies can navigate the increasingly complex and interconnected regulatory frameworks across the United States, European Union, China, and others. Topics will include planned EU MDR adjustments, the growing adoption of electronic Instructions for Use (eIFU), and the rise of global reliance frameworks. Panelists will also examine developments in digital health oversight, and the impact of horizontal legislation such as the EU AI Act and cross-sectoral AI initiatives. Environmental sustainability and its intersection with product development may also be discussed, along with strategies for integrating regulatory planning into broader business decisions. Attendees will gain insights into how to future-proof operations and position their innovations for success in a rapidly evolving global market.
Tuesday, January 13 | 9:00 a.m. PT
Life Sciences Liquidity: Making Waves in M&A
Join us for an exclusive fireside chat at the J.P. Morgan Healthcare Conference, where industry leaders will unpack the most significant issues shaping the future of M&A in 2026. From navigating the complexities of public and private transactions to understanding the evolving regulatory and market dynamics, this conversation will provide actionable insights for executives, investors, and innovators. Attendees will gain clarity on emerging life sciences & health care M&A trends, and learn how to identify opportunities in the current market.
Tuesday, January 13 | 11:00 a.m. PT
Revenue Generation and Risk Sharing in Global Licensing & Collaboration Transactions
Leading industry experts will review the latest trends in licensing and collaboration across the United States, United Kingdom, and European Union. With novel regulatory frameworks, market dynamics, and supply chain pressures influencing deal structures and partnership models, legal and regulatory acuity is essential for success in 2026. Attendees will gain clarity on how to leverage licensing agreements in order to accelerate innovation and expand global reach. From co-development opportunities to risk-sharing arrangements, we’ll illuminate best practices for structuring partnerships that help companies stay ahead of the curve.
Tuesday, January 13 | 1:30 p.m. PT
Liquidity Unlocked: Capital Markets and Royalty Monetizations
From traditional public offerings to PIPEs to royalty monetization and other financing strategies, attendees will gain insights into how these mechanisms are driving strategic growth in a rapidly shifting regulatory environment. There will also be the opportunity for Q&A with our leading industry experts, who can help you understand the practical realities of innovative paths to funding, such as de-SPACs as well as traditional and synthetic royalty monetization transactions.
Wednesday, January 14 | 9:00 a.m. PT
Women’s Breakfast: Trailblazers in Life Sciences
Join us for a dynamic conversation that celebrates and empowers women leaders in life sciences, women’s health, and entrepreneurship, which will bring together trailblazing women at the forefront of innovation, research, and business. This event, moderated by Kristin Connarn, partner in the Hogan Lovells intellectual property practice, offers a unique platform for networking, inspiration, and collaboration.
Back To Listing
